These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17980713)

  • 1. The post-transcriptional roles of WT1, a multifunctional zinc-finger protein.
    Morrison AA; Viney RL; Ladomery MR
    Biochim Biophys Acta; 2008 Jan; 1785(1):55-62. PubMed ID: 17980713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
    Morrison AA; Venables JP; Dellaire G; Ladomery MR
    Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
    Ullmark T; Montano G; Gullberg U
    Eur J Haematol; 2018 Mar; 100(3):229-240. PubMed ID: 29240258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).
    Toska E; Roberts SG
    Biochem J; 2014 Jul; 461(1):15-32. PubMed ID: 24927120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis.
    Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U
    Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of gene expression by WT1 in development and tumorigenesis.
    Ellisen LW
    Int J Hematol; 2002 Aug; 76(2):110-6. PubMed ID: 12215008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the Wilms' tumour-suppressor protein WT1 in apoptosis.
    Hartkamp J; Roberts SG
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):629-31. PubMed ID: 18631130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex life of WT1.
    Wagner KD; Wagner N; Schedl A
    J Cell Sci; 2003 May; 116(Pt 9):1653-8. PubMed ID: 12665546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
    Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM
    Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.
    Ladomery MR; Slight J; Mc Ghee S; Hastie ND
    J Biol Chem; 1999 Dec; 274(51):36520-6. PubMed ID: 10593950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic behaviour of WT 1's zinc finger domain in binding to the alpha-actinin-1 mRNA.
    Nurmemmedov E; Yengo RK; Ladomery MR; Thunnissen MM
    Arch Biochem Biophys; 2010 May; 497(1-2):21-7. PubMed ID: 20193655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.
    Larsson SH; Charlieu JP; Miyagawa K; Engelkamp D; Rassoulzadegan M; Ross A; Cuzin F; van Heyningen V; Hastie ND
    Cell; 1995 May; 81(3):391-401. PubMed ID: 7736591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional properties of WT1.
    Haber DA; Englert C; Maheswaran S
    Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
    Sakamoto Y; Yoshida M; Semba K; Hunter T
    Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of WT1 in nuclear messenger RNP particles in the human acute myeloid leukemia cell lines HL60 and K562.
    Morrison AA; Ladomery MR
    Cancer Lett; 2006 Nov; 244(1):136-41. PubMed ID: 16457949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.